Back

Clinical characteristics and outcomes of patients with takotsubo syndrome and dynamic left ventricular outflow tract obstruction

30 August 2024 (08:00 - 17:30)
Organised by: Logo
Congress Presentation Part of: Takotsubo cardiomyopathy and acute coronary syndromes Epidemiology, Prognosis, Outcome ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

About the speaker

Photo
Doctor Davide Di Vece

University Hospital of Greifswald, Greifswald (Germany)

5 More presentations in this session

Presentation thumbnail
Cardiac autonomic dysfunction in Takotsubo cardiomyopathy: an observational study
Doctor F. Hofer (Innsbruck, AT)
Abstract Slides Video
Presentation thumbnail
Prognostic impact of secondary prevention medical therapy in patients with Takotsubo cardiomyopathy: a Bayesian network meta-analysis
Doctor A. Zaka (Southport, AU)
Abstract Slides Video
Presentation thumbnail
A personalized, 3D printed, polymeric elastic support device for the prevention of post-MI cardiac remodeling
Doctor D. Nachman (Jerusalem, IL)
Abstract Slides Video
Presentation thumbnail
Guideline-directed medical therapy titration for heart failure with ischaemic aetiology and its effect on cardiac remodelling and cardiovascular mortality-from a real world perspective
Doctor J. Bonini (Ferrara, IT)
Abstract Slides Video
Presentation thumbnail
Utility of venoarterial extracorporeal membrane oxygenation in patients with acute myocardial infarction complicated by cardiogenic shock
Doctor S. Gupta (Stony Brook, US)
Abstract Slides Video

Access the full session

Session thumbnail
Takotsubo cardiomyopathy and acute coronary syndromes

The Event

Event poster

ESC Congress 2024

30 August - 2 September 2024
You may be interested in
thumbnail
Congress Presentation
Takotsubo syndrome stress induced heart failure syndrome with significant LVOT obstruction
thumbnail
Congress Presentation
Clinical features and outcomes of takotsubo syndrome
thumbnail
Congress Presentation
Cardiovascular and non-cardiovascular prescribing and mortality after takotsubo

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources